SDGR
NASDAQ
$15
Schrodinger Inc (SDGR)
Schrdinger, Inc. provides a physics-based software platform that enables the discovery of novel molecules for drug development and material applications. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Health Information Services
Buy
Target: $20.57 (+37.13%)
Market Cap
$1.20B
Free Cash Flow Yield
-12.32%
Beta (5Y)
1.47
Price Chart
Valuation
Market Cap$1.20B
P/S4.77
P/B3.84
Profitability
Total Revenue (TTM)$255M
Gross Profit (TTM)$141M
EBITDA-$159M
Profit Margin-40.6%
Operating Margin-83.3%
EPS-$2.66
Financial Health
Free Cash Flow Yield-12.32%
Growth & Risk
Revenue 5Y CAGR+17.45%
Beta (5Y)1.47
Sharpe Ratio-0.51